Contributors

Annika Schilling
Life/Health Underwriting Manager, Cologne
Annika Schilling is Head of Underwriting Research, Research and Development based in Gen Re’s Cologne office. She is responsible for Gen Re’s underwriting manuals and providing support to clients on questions related to underwriting.
-
Comprendre l’hépatite virale - Quels sont les éléments pertinents en vue de l’adhésion ?
By Dr. Sandra Mitic and Annika Schilling Jul 22, 2020 Français
La prévalence, les thérapies actuelles et la prévention sont les thèmes clés pour les assureurs qui revoient leur approche de l’analyse des dossiers d’adhésion des proposants ayant des antécédents d’hépatite virale. L’hépatite virale est le terme utilisé...
Read More -
Understanding Viral Hepatitis - What’s Relevant to Underwriting?
By Dr. Sandra Mitic and Annika Schilling Jan 23, 2020 English
Prevalence, current therapies and prevention are the key themes for insurers that are reviewing their approach to applications with a history of viral hepatitis. As its name suggests, viral hepatitis is the term used to describe diffuse inflammation of...
Read More -
Avancées médicales et contrôles de faisabilité du point de vue des assureurs
By Annika Schilling Dec 16, 2019 Français
Il y a quelques mois, des chercheurs de l’Hôpital universitaire d’Heidelberg ont annoncé le développement d’un test sanguin permettant de détecter les cellules cancéreuses à l’origine du cancer du sein chez les patientes avec une plus grande précision...
Read More -
Medical Advances and Reality Checks for Underwriters
By Annika Schilling Aug 06, 2019 English
Earlier this year researchers at Heidelberg University Hospital announced the development of a blood test that can detect breast cancer cells in patients - with higher accuracy than mammography. Around the same time it was reported that a second and third...
Read More